Serodus ASA Stock

Stocks

17-01-02	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
16-12-08	Serodus : Q&A delisting from Oslo Axess	PU
16-11-23	Serodus : Extraordinary general meeting held	PU
16-11-23	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
16-11-02	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	2022-12-31
Henrik Mordhorst DFI	Director of Finance/CFO	-	2019-09-30
Daniel Capion PRN	Corporate Officer/Principal	-	2020-12-31

Director	Title	Age	Since
Søren Elmann Ingerslev CHM	Chairman	-	2016-12-31
Terri Sebree BRD	Director/Board Member	68	2014-03-31
Viggo Gunnersen Harboe BRD	Director/Board Member	80	2021-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	-3.30%	+1.50%	+57.79%	+99.14%	72.26B
ARGENX SE	+1.25%	-3.01%	+37.83%	+87.66%	60.24B
WUXI BIOLOGICS (CAYMAN) INC.	+2.12%	+5.26%	+35.69%	+23.40%	27.73B
INSMED INCORPORATED	-3.06%	-1.81%	-14.01%	+357.24%	25.73B
BIONTECH SE	-0.75%	+2.56%	+0.45%	-3.28%	24.75B
GENMAB A/S	+0.40%	+0.75%	+23.72%	-11.33%	20.74B
PHARMAESSENTIA CORPORATION	-1.70%	-2.12%	+150.24%	+326.97%	15.06B
EXELIXIS, INC.	+0.36%	-0.34%	+48.98%	+167.40%	14.41B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.21%	+1.17%	-3.95%	+512.06%	14.23B
Average	-1.00%	+0.44%	+37.41%	+173.25%	30.57B
Weighted average by Cap.	-0.77%	+0.31%	+38.16%	+132.99%

Employees

Sector